empty
 
 
id
Cari
Bantuan
Pembukaan akun instan
Platform Trading
Deposit/Penarikan
Cari
P2P Pertukaran Pasar Keuangan Untuk Kitra Forum Tentang perusahaan
id
#ALNY Kembali ke daftar instrumen #AUPH

Konverter mata uang

Amgen Inc.
279.77 USD
26 Nov 2024 22:59
Perubahan Harga (% chg)
$-0.04
(-0.01%)
Penutupan Sebelumnya
Penutupan Sebelumnya

Harga penutupan, hari sebelumnya.
$293.3
Buka
Buka

Harga pembukaan.
$293.93
Ketinggian Harian
Ketinggian Harian

Harga tertinggi pada hari transaksi terakhir.
$280.4
Kerendahan Harian
Kerendahan Harian

Harga terendah pada hari transaksi terakhir
$257.69
Kapitalisasi pasar
Kapitalisasi pasar

Nilai total perusahaan dalam pasar saham. Umumnya dihitung dengan menggandakan saham-saham yang beredang dengan harga saham saat itu.
$280.95
Saham Beredar
Saham Beredar

Jumlah saham yang dipegang oleh para investor dan insider perusahaan, diluar sekuritas dilutif (dilutive securities) seperti non-vested RSU dan unexercised options.
$257.69
Unduh arsip
Beli
279.77
Jual
279.77
Buka tabel dalam tampilan layar penuh
Beli
279.77
Jual
279.77
Unduh arsip
Buka tabel dalam tampilan layar penuh

About Amgen Inc.

Amgen Inc. is one of the world's leading biotechnology companies. Founded in 1980 in the United States, it currently operates in more than 70 countries around the world.

Amgen focuses on developing cutting-edge medicines against cancer, cardiovascular diseases, bone ailments, kidney diseases and other afflictions.

The company currently has a market capitalization of $122.5 billion. Amgen reported revenues of $25.98 billion and a net income of $5.89 billion in 2021.

Amgen Inc. stock and what affects it

The company stock is listed on the NASDAQ exchange under the ticker name AMGN. When the company had its initial public offering in 1983, its shares were priced between $16 and $19 at the time.

Now, Amgen's shares are trading between $227 and $231. Last year, it fluctuated from $198 to $258. Forecasts suggest the stock will continue to climb.

When trading this asset, you have to keep the following things in mind:

  • The company has a dominant position in the market.
  • There are potential opportunities to capitalize on its products and strategic initiatives.
  • Threats to Amgen include its competition, government regulation, and the company’s dependence on wholesale distributors.

Tidak bisa bicara sekarang?
Tanyakan pertanyaan anda lewat chat.